Tokenization of Oncology Adjuvant and CAMs using extract from Rice

Keywords: Oncology adjuvant, CAMs, DeFi, Web 3.0 tokenization, Licensing, patent, IP Our effort is to tokenize intellectual property and commercialize academic research, which allows everyone to invest in pharmaceutical projects. We acquire the license for patented Bionis, which is a joint effort of more than 10 scientists. Bionis is an active ingredient that is extracted from rice but is otherwise not available through digestion. It will be developed as a TGA-approved oncology adjuvant and FDA-approved CAMs. Coin holders will be allowed to redeem a coupon that can buy a full course of our product at a 35% discount. Our oncology adjuvant has gone through animal tests. Animals taking chemotherapy usually die before they finish the whole course. Taking our Bionis will allow them to finish the therapy and extend their life. We plan to finish all the clinical tests and achieve TGA approval in about 10 years' time. Our CAMs can attain FDA approval in about 3 years' time.